falseJanuary 31, 20260001715925Q3--04-300001715925ifrs-full:IssuedCapitalMember2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925ifrs-full:RestrictedShareUnitsMember2025-05-012026-01-310001715925hyft:OptionTwelveMember2025-05-012026-01-310001715925hyft:OptionEightMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2026-01-310001715925ifrs-full:LeaseLiabilitiesMember2025-05-012026-01-310001715925ifrs-full:RetainedEarningsMember2025-01-310001715925ifrs-full:RetainedEarningsMember2025-10-310001715925ifrs-full:RetainedEarningsMember2025-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2024-05-012025-04-3000017159252025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-05-012026-01-310001715925ifrs-full:VehiclesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:ProductSalesMember2025-11-012026-01-310001715925hyft:DeferredAcquisitionPaymentsMember2025-05-012026-01-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-05-012026-01-310001715925country:NL2024-11-012025-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-05-012026-01-310001715925hyft:AccumulatedDepreciationAmountMember2026-01-310001715925hyft:ImmunoPreciseAntibodiesNDLtdMember2024-03-012025-04-300001715925ifrs-full:GrossCarryingAmountMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-05-012026-01-310001715925hyft:OptionFourMember2026-01-310001715925hyft:ProductSalesMember2024-05-012025-01-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-01-310001715925hyft:OptionElevenMember2026-01-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-05-012026-01-310001715925ifrs-full:WeightedAverageMemberhyft:LabEquipmentMember2025-05-012026-01-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2024-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2026-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2025-10-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:FindersWarrantsMember2023-05-012024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2024-04-300001715925country:AU2025-05-012026-01-310001715925hyft:NetBookValueMemberhyft:CertificationsMember2025-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-05-012026-01-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-04-300001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2026-01-310001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925hyft:NetBookValueMember2025-04-300001715925ifrs-full:IssuedCapitalMember2024-05-012025-01-310001715925hyft:FindersWarrantsMemberhyft:RangeOneMember2026-01-310001715925ifrs-full:RestrictedShareUnitsMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-04-300001715925hyft:BioclueB.vMember2024-03-012025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2026-01-310001715925hyft:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2024-03-012025-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-05-012026-01-310001715925country:NL2024-05-012025-01-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925hyft:OptionFourMember2025-05-012026-01-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925hyft:CryoStorageMember2025-11-012026-01-310001715925hyft:ProprietaryProcessesMemberhyft:NetBookValueMember2025-04-300001715925hyft:CryoStorageMember2024-05-012025-01-310001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2024-05-012025-04-300001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2026-01-310001715925ifrs-full:DiscontinuedOperationsMember2026-01-3100017159252025-10-310001715925hyft:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2026-01-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925hyft:LabAndOfficeFacilitiesMember2026-01-310001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:BiokeyB.vMember2025-05-012026-01-310001715925hyft:AllOtherCountriesMember2025-11-012026-01-310001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2026-01-310001715925hyft:NetBookValueMemberhyft:IntellectualPropertiesMember2025-04-300001715925ifrs-full:NotLaterThanOneYearMember2026-01-310001715925hyft:OptionTwoMember2025-05-012026-01-310001715925hyft:IdeaFamilyB.vMember2024-03-012025-04-300001715925ifrs-full:RetainedEarningsMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-05-012026-01-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2026-01-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2024-04-300001715925ifrs-full:RetainedEarningsMember2024-04-300001715925ifrs-full:DiscontinuedOperationsMember2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2024-05-012025-04-300001715925srt:NorthAmericaMember2025-04-300001715925hyft:AtTheMarketEquityOfferingFacilityMember2024-05-012025-04-300001715925hyft:NetBookValueMemberhyft:AutomobileMember2025-04-300001715925ifrs-full:BottomOfRangeMemberhyft:LabEquipmentMember2025-05-012026-01-3100017159252025-01-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:AccumulatedDepreciationAmountMember2024-04-300001715925hyft:OptionSixMember2026-01-310001715925country:BE2025-11-012026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2026-01-310001715925hyft:NetBookValueMemberhyft:AutomobileMember2026-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-01-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-04-300001715925ifrs-full:RestrictedShareUnitsMember2026-01-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2024-04-300001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925srt:NorthAmericaMember2025-05-012026-01-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2024-04-300001715925srt:EuropeMember2024-11-012025-01-310001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2026-01-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-11-012025-01-310001715925ifrs-full:LeaseLiabilitiesMember2025-04-300001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2026-01-310001715925hyft:DebenturesMember2024-05-012025-01-310001715925hyft:ProjectRevenueMember2024-05-012025-01-310001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2025-04-300001715925ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2026-01-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2024-04-300001715925hyft:OptionFiveMember2025-05-012026-01-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2026-01-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2024-04-300001715925hyft:CryoStorageMember2024-11-012025-01-310001715925country:AU2024-11-012025-01-310001715925country:NL2025-05-012026-01-3100017159252023-05-012024-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925hyft:NetBookValueMemberifrs-full:FixturesAndFittingsMember2026-01-310001715925hyft:MindWalkBiologicsMember2025-05-012026-01-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2024-05-012025-04-300001715925ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2026-01-310001715925hyft:DeferredAcquisitionPaymentsMember2024-04-3000017159252025-11-012026-01-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:IssuedCapitalMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2026-01-310001715925hyft:DeferredAcquisitionPaymentsMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-10-310001715925hyft:ProjectRevenueMember2025-05-012026-01-310001715925hyft:OptionThreeMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2024-04-300001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2026-01-310001715925hyft:OptionSixMember2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2024-04-300001715925hyft:ImmunoPreciseNetherlandsBVMember2025-05-012026-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-10-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:ImmunoPreciseAntibodiesEuropeBVIPAEuropeFormerlyModiQuestResearchBVMember2024-03-012025-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2026-01-310001715925ifrs-full:TopOfRangeMemberhyft:LabAndOfficeFacilitiesMember2025-05-012026-01-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2025-05-012026-01-310001715925hyft:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2025-05-012026-01-310001715925country:CA2024-05-012025-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-11-012026-01-310001715925ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2026-01-310001715925ifrs-full:DiscontinuedOperationsMember2024-11-012025-01-310001715925ifrs-full:RestrictedShareUnitsMember2024-04-300001715925country:US2024-05-012025-01-310001715925hyft:NetBookValueMemberifrs-full:VehiclesMember2026-01-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2025-04-3000017159252024-05-012025-01-310001715925hyft:OfficersAndEmployeesMemberhyft:ThreeAugustTwentyTwentyFourMember2025-05-012026-01-310001715925hyft:DebenturesMember2024-04-300001715925srt:EuropeMember2024-05-012025-01-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2026-01-310001715925srt:EuropeMember2025-05-012026-01-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-11-012026-01-310001715925hyft:LabEquipmentMemberhyft:NetBookValueMember2026-01-310001715925ifrs-full:RestrictedShareUnitsMember2025-04-300001715925hyft:DebenturesMember2025-01-310001715925hyft:AccumulatedDepreciationAmountMember2024-05-012025-04-300001715925hyft:ConvertibleDebenturesMemberhyft:YaIiPnLtdMemberhyft:TrancheTwoMember2024-07-160001715925ifrs-full:IssuedCapitalMember2024-10-310001715925hyft:OptionNineMember2026-01-310001715925hyft:OfficersAndEmployeesMemberhyft:ThreeAugustTwentyTwentyFourMember2026-01-310001715925hyft:MindWalkBiologicsMember2024-03-012025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-11-012026-01-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-05-012026-01-310001715925hyft:FindersWarrantsMember2025-05-012026-01-310001715925ifrs-full:BottomOfRangeMemberhyft:LabAndOfficeFacilitiesMember2025-05-012026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2024-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2024-04-300001715925srt:EuropeMember2025-11-012026-01-310001715925hyft:IdeaFamilyB.vMember2025-05-012026-01-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2026-01-310001715925hyft:AtTheMarketEquityOfferingFacilityMember2025-04-300001715925country:US2024-11-012025-01-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925ifrs-full:DiscontinuedOperationsMember2025-11-012026-01-310001715925hyft:ImmunoPreciseAntibodiesEuropeBVIPAEuropeFormerlyModiQuestResearchBVMember2025-05-012026-01-310001715925hyft:NetBookValueMemberifrs-full:VehiclesMember2025-04-300001715925hyft:RangeTwoMemberhyft:FindersWarrantsMember2025-05-012026-01-310001715925ifrs-full:IssuedCapitalMember2025-01-310001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2024-04-300001715925hyft:AccumulatedDepreciationAmountMember2025-05-012026-01-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2024-05-012025-04-300001715925hyft:BiokeyB.vMember2024-03-012025-04-300001715925ifrs-full:TopOfRangeMemberifrs-full:VehiclesMember2025-05-012026-01-310001715925hyft:ProductSalesMember2024-11-012025-01-310001715925hyft:ConvertibleDebenturesMemberhyft:YaIiPnLtdMember2024-07-160001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2024-05-012025-04-300001715925hyft:NetBookValueMemberhyft:ComputerHardwareMember2025-04-300001715925hyft:DeferredAcquisitionPaymentsMember2025-01-310001715925hyft:OptionThirteenMember2025-05-012026-01-310001715925hyft:AllOtherCountriesMember2025-05-012026-01-310001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2025-04-300001715925hyft:OptionSevenMember2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-05-012026-01-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:NetBookValueMemberhyft:LabEquipmentMember2025-04-300001715925hyft:FindersWarrantsMember2024-04-300001715925country:BE2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-05-012026-01-310001715925country:AU2025-11-012026-01-310001715925srt:NorthAmericaMember2024-05-012025-01-310001715925hyft:OptionOneMember2026-01-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925country:US2025-05-012026-01-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-04-300001715925hyft:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925hyft:NetBookValueMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925country:BE2024-11-012025-01-310001715925hyft:AtTheMarketEquityOfferingFacilityMember2026-01-310001715925country:NL2026-01-310001715925ifrs-full:TopOfRangeMemberhyft:LabEquipmentMember2025-05-012026-01-310001715925ifrs-full:LeaseLiabilitiesMember2024-04-300001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2024-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-04-300001715925ifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:ImmunoPreciseAntibodiesMALLCMember2025-05-012026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-05-012026-01-310001715925ifrs-full:LeaseLiabilitiesMember2026-01-310001715925ifrs-full:DiscontinuedOperationsMember2024-05-012025-01-310001715925hyft:FindersWarrantsMember2024-05-012025-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-04-300001715925hyft:OptionTwoMember2026-01-310001715925hyft:OptionThreeMember2025-05-012026-01-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2024-05-012025-01-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2026-01-310001715925ifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2024-05-012025-04-300001715925hyft:ConvertibleDebenturesMemberhyft:YaIiPnLtdMemberhyft:TrancheOneMember2024-07-160001715925hyft:NetBookValueMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2024-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2024-11-012025-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2026-01-310001715925ifrs-full:LeaseLiabilitiesMember2025-01-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-05-012026-01-310001715925hyft:MindWalkBVMember2024-03-012025-04-300001715925ifrs-full:BottomOfRangeMemberifrs-full:VehiclesMember2025-05-012026-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2024-05-012025-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2024-05-012025-04-300001715925ifrs-full:VehiclesMemberifrs-full:WeightedAverageMember2025-05-012026-01-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2025-04-3000017159252024-05-012025-04-300001715925hyft:OptionFiveMember2026-01-310001715925hyft:NetBookValueMemberhyft:ComputerHardwareMember2026-01-310001715925hyft:LabEquipmentMemberhyft:NetBookValueMember2025-04-300001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2024-04-300001715925hyft:FindersWarrantsMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2024-04-300001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:LabEquipmentMember2025-05-012026-01-310001715925ifrs-full:IssuedCapitalMember2025-11-012026-01-310001715925hyft:OptionSevenMember2026-01-310001715925hyft:OptionOneMember2025-05-012026-01-3100017159252024-04-300001715925hyft:AtTheMarketEquityOfferingFacilityMember2025-11-072025-11-070001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2024-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2024-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-05-012026-01-310001715925country:BE2026-01-310001715925srt:NorthAmericaMember2025-11-012026-01-3100017159252024-11-012025-01-310001715925hyft:ImmunoPreciseAntibodiesMALLCMember2024-03-012025-04-300001715925hyft:DeferredAcquisitionPaymentsMember2024-05-012025-01-310001715925hyft:OptionTwelveMember2026-01-310001715925hyft:DeferredAcquisitionPaymentsMember2025-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-04-300001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:TalemTherapeuticsLLCTalemMember2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-04-3000017159252025-05-012026-01-310001715925hyft:ProprietaryProcessesMemberhyft:NetBookValueMember2026-01-310001715925ifrs-full:IssuedCapitalMemberifrs-full:OrdinarySharesMember2025-04-300001715925hyft:AccumulatedDepreciationAmountMember2025-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2026-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2025-01-310001715925country:NL2025-04-300001715925hyft:RangeTwoMemberhyft:FindersWarrantsMember2026-01-3100017159252022-05-310001715925hyft:NetBookValueMemberhyft:InternallyGeneratedDevelopmentCostsMember2026-01-310001715925hyft:AllOtherCountriesMember2024-11-012025-01-310001715925hyft:NetBookValueMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-04-300001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2025-05-012026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2024-05-012025-04-300001715925ifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:NetBookValueMemberhyft:LabEquipmentMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2024-05-012025-04-300001715925hyft:OptionTenMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2024-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:ProjectRevenueMember2025-11-012026-01-310001715925country:AU2024-05-012025-01-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2024-05-012025-04-300001715925country:CA2025-05-012026-01-310001715925hyft:AccumulatedDepreciationAmountMemberhyft:LabEquipmentMember2024-05-012025-04-300001715925hyft:TalemTherapeuticsLLCTalemMember2024-03-012025-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-04-300001715925hyft:NetBookValueMemberhyft:InternallyGeneratedDevelopmentCostsMember2025-04-300001715925hyft:ImmunoPreciseNetherlandsBVMember2024-03-012025-04-300001715925ifrs-full:VehiclesMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925ifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925hyft:ProductSalesMember2025-05-012026-01-310001715925hyft:CryoStorageMember2025-05-012026-01-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-05-012026-01-310001715925hyft:LabEquipmentMember2026-01-310001715925hyft:NetBookValueMemberifrs-full:CustomerrelatedIntangibleAssetsMember2026-01-310001715925hyft:NetBookValueMemberhyft:CertificationsMember2026-01-3100017159252024-10-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925country:BE2024-05-012025-01-310001715925hyft:BioclueB.vMember2025-05-012026-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-05-012025-01-3100017159252026-01-310001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2025-04-300001715925hyft:NetBookValueMemberhyft:IntellectualPropertiesMember2026-01-310001715925country:CA2025-11-012026-01-310001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2025-05-012026-01-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2025-05-012026-01-310001715925hyft:ImmunoPreciseAntibodiesNDLtdMember2025-05-012026-01-310001715925hyft:OptionTenMember2025-05-012026-01-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-05-012026-01-310001715925ifrs-full:VehiclesMember2026-01-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-05-012026-01-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2024-05-012025-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2024-10-310001715925hyft:FindersWarrantsMemberhyft:RangeOneMember2025-05-012026-01-310001715925ifrs-full:BuildingsMemberhyft:AccumulatedDepreciationAmountMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2026-01-310001715925srt:NorthAmericaMember2026-01-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2024-05-012025-04-300001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925ifrs-full:VehiclesMemberifrs-full:GrossCarryingAmountMember2026-01-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:OptionFourAndFiveMember2026-01-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2024-11-012025-01-310001715925hyft:NetBookValueMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2024-05-012025-04-300001715925ifrs-full:IssuedCapitalMemberifrs-full:OrdinarySharesMember2024-05-012025-04-300001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-01-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925srt:NorthAmericaMember2024-11-012025-01-310001715925ifrs-full:IssuedCapitalMember2025-10-310001715925country:US2025-11-012026-01-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2024-04-300001715925hyft:MindWalkBVMember2025-05-012026-01-310001715925hyft:OptionEightMember2025-05-012026-01-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-04-300001715925hyft:FindersWarrantsMember2025-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2026-01-310001715925hyft:OptionNineMember2025-05-012026-01-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2026-01-310001715925ifrs-full:IssuedCapitalMember2024-04-300001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925hyft:OptionSevenToTwelveMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2024-04-300001715925hyft:OptionElevenMember2025-05-012026-01-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2024-05-012025-04-300001715925country:CA2024-11-012025-01-310001715925hyft:NetBookValueMemberifrs-full:CustomerrelatedIntangibleAssetsMember2025-04-300001715925hyft:MindWalkBVMember2026-01-310001715925ifrs-full:LeaseLiabilitiesMember2024-05-012025-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2025-04-300001715925hyft:AllOtherCountriesMember2024-05-012025-01-310001715925ifrs-full:LaterThanFiveYearsMember2026-01-310001715925ifrs-full:IssuedCapitalMember2024-11-012025-01-310001715925ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2026-01-310001715925ifrs-full:RetainedEarningsMember2025-11-012026-01-310001715925country:BE2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-05-012026-01-310001715925ifrs-full:RetainedEarningsMember2025-05-012026-01-310001715925ifrs-full:RetainedEarningsMember2024-11-012025-01-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2024-05-012025-04-300001715925ifrs-full:CustomerrelatedIntangibleAssetsMemberhyft:AccumulatedAmortizationMember2024-05-012025-04-300001715925hyft:ProjectRevenueMember2024-11-012025-01-310001715925hyft:OptionThirteenMember2026-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925ifrs-full:RetainedEarningsMember2024-05-012025-01-310001715925ifrs-full:IssuedCapitalMember2025-04-300001715925country:NL2025-11-012026-01-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:LabAndOfficeFacilitiesMemberifrs-full:WeightedAverageMember2025-05-012026-01-310001715925hyft:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2024-05-012025-04-300001715925ifrs-full:RetainedEarningsMember2024-10-31iso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:sharesiso4217:CADiso4217:CADxbrli:sharesiso4217:USDutr:Y

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2026.

Commission File Number: 001-39530

MindWalk Holdings Corp.

3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.


Form 20-F ☒	Form 40-F ☐

INCORPORATION BY REFERENCE

Exhibits 99.1 and 99.2 of this Form 6-K are incorporated by reference into the Registration Statements on Form S-8 (File Nos. 333-256730 and 333-290949) and Registration Statements on Form F-3 (File Nos. 333-273197 and 333-281312) of the Registrant, MindWalk Holdings Corp.

EXHIBIT INDEX

Exhibit	Description
99.1	~~Press~~Management’s ~~Release~~Discussion ~~dated~~and ~~March~~Analysis 6for the three and nine months ended January 31, 2026 and 2025
99.2	Condensed Interim Consolidated Financial Statements for the three and nine months ended January 31, 2026 and 2025
99.3	CEO Certification (pursuant to Canadian regulations)
99.4	CFO Certification (pursuant to Canadian regulations)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MINDWALK HOLDINGS CORP.
Date: March 6, 2026
Date: March 12, 2026
	By:	/s/ Jennifer Bath
	Name:	Jennifer Bath
	Title:	~~President and~~ Chief Executive Officer

Filing Compare · MindWalk Holdings Corp.